| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neural Tube Defects | 17 | 2024 | 356 | 2.310 |
Why?
|
| Folic Acid | 15 | 2024 | 294 | 2.000 |
Why?
|
| Folate Receptor 1 | 8 | 2024 | 30 | 1.280 |
Why?
|
| Oxazines | 2 | 2024 | 25 | 1.050 |
Why?
|
| Pyridones | 2 | 2024 | 119 | 0.970 |
Why?
|
| Piperazines | 2 | 2024 | 241 | 0.920 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 2 | 2024 | 39 | 0.870 |
Why?
|
| Spinal Dysraphism | 5 | 2022 | 270 | 0.830 |
Why?
|
| Sertraline | 2 | 2020 | 44 | 0.790 |
Why?
|
| Zebrafish | 3 | 2019 | 379 | 0.700 |
Why?
|
| Autoantibodies | 6 | 2018 | 435 | 0.660 |
Why?
|
| Folic Acid Deficiency | 5 | 2024 | 53 | 0.620 |
Why?
|
| Zebrafish Proteins | 1 | 2019 | 115 | 0.610 |
Why?
|
| Neural Tube | 3 | 2020 | 46 | 0.610 |
Why?
|
| Pregnancy | 19 | 2024 | 7209 | 0.570 |
Why?
|
| Embryonic Stem Cells | 2 | 2020 | 163 | 0.560 |
Why?
|
| Blood-Brain Barrier | 2 | 2015 | 141 | 0.560 |
Why?
|
| Self Administration | 3 | 2016 | 43 | 0.550 |
Why?
|
| Neural Crest | 1 | 2017 | 56 | 0.550 |
Why?
|
| Receptors, Cell Surface | 6 | 2013 | 470 | 0.540 |
Why?
|
| Mice | 27 | 2024 | 17635 | 0.510 |
Why?
|
| Conditioning, Classical | 1 | 2015 | 54 | 0.480 |
Why?
|
| Antidepressive Agents | 1 | 2017 | 294 | 0.470 |
Why?
|
| HIV Infections | 2 | 2024 | 1899 | 0.450 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-2 | 1 | 2014 | 14 | 0.440 |
Why?
|
| Social Behavior | 1 | 2015 | 208 | 0.440 |
Why?
|
| Cocaine | 1 | 2015 | 207 | 0.430 |
Why?
|
| Teratogens | 4 | 2018 | 88 | 0.430 |
Why?
|
| Behavior, Animal | 1 | 2015 | 490 | 0.410 |
Why?
|
| Animals | 31 | 2024 | 34238 | 0.380 |
Why?
|
| Gene Expression Profiling | 3 | 2012 | 1711 | 0.380 |
Why?
|
| Toxicity Tests | 3 | 2020 | 35 | 0.360 |
Why?
|
| Disease Models, Animal | 6 | 2020 | 4396 | 0.330 |
Why?
|
| Carrier Proteins | 4 | 2010 | 1022 | 0.320 |
Why?
|
| Paroxetine | 2 | 2020 | 28 | 0.310 |
Why?
|
| Cell Line | 5 | 2020 | 2756 | 0.290 |
Why?
|
| Environmental Pollutants | 2 | 2020 | 68 | 0.290 |
Why?
|
| Valproic Acid | 4 | 2018 | 166 | 0.280 |
Why?
|
| Folate Receptors, GPI-Anchored | 5 | 2018 | 54 | 0.280 |
Why?
|
| Tacrolimus Binding Proteins | 2 | 2020 | 66 | 0.270 |
Why?
|
| Repressor Proteins | 2 | 2022 | 813 | 0.260 |
Why?
|
| Embryonic Development | 2 | 2019 | 214 | 0.260 |
Why?
|
| Vitamin B 12 | 2 | 2013 | 59 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 12 | 2020 | 4406 | 0.250 |
Why?
|
| Models, Animal | 2 | 2019 | 464 | 0.250 |
Why?
|
| Nervous System | 2 | 2004 | 127 | 0.240 |
Why?
|
| Homeodomain Proteins | 3 | 2020 | 548 | 0.240 |
Why?
|
| Fumonisins | 1 | 2004 | 2 | 0.240 |
Why?
|
| Embryo, Nonmammalian | 3 | 2018 | 143 | 0.230 |
Why?
|
| Female | 24 | 2024 | 66844 | 0.210 |
Why?
|
| Central Nervous System | 1 | 2004 | 255 | 0.210 |
Why?
|
| Loss of Function Mutation | 2 | 2020 | 149 | 0.200 |
Why?
|
| Homocysteine | 2 | 2016 | 123 | 0.200 |
Why?
|
| Proton-Coupled Folate Transporter | 2 | 2012 | 6 | 0.190 |
Why?
|
| Embryo, Mammalian | 5 | 2016 | 460 | 0.190 |
Why?
|
| Mice, Transgenic | 4 | 2018 | 2397 | 0.180 |
Why?
|
| Anticonvulsants | 5 | 2020 | 383 | 0.180 |
Why?
|
| Immunoglobulin G | 3 | 2016 | 777 | 0.180 |
Why?
|
| Wnt3A Protein | 1 | 2020 | 12 | 0.180 |
Why?
|
| Tetrahydrofolates | 1 | 2020 | 17 | 0.180 |
Why?
|
| Cerebrum | 1 | 2020 | 33 | 0.170 |
Why?
|
| Humans | 26 | 2024 | 125269 | 0.170 |
Why?
|
| Organotin Compounds | 1 | 2020 | 6 | 0.170 |
Why?
|
| Citalopram | 1 | 2020 | 30 | 0.170 |
Why?
|
| Mice, Inbred ICR | 1 | 2020 | 149 | 0.160 |
Why?
|
| HIV Integrase Inhibitors | 1 | 2019 | 12 | 0.160 |
Why?
|
| Abnormalities, Drug-Induced | 3 | 2018 | 92 | 0.160 |
Why?
|
| Teratogenesis | 1 | 2018 | 8 | 0.150 |
Why?
|
| Membrane Transport Proteins | 2 | 2018 | 175 | 0.150 |
Why?
|
| Gene Expression | 5 | 2020 | 1560 | 0.150 |
Why?
|
| Nervous System Diseases | 2 | 2020 | 375 | 0.150 |
Why?
|
| Dietary Supplements | 2 | 2019 | 472 | 0.150 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2018 | 36 | 0.150 |
Why?
|
| Formates | 1 | 2018 | 13 | 0.150 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2007 | 1005 | 0.150 |
Why?
|
| Amides | 1 | 2018 | 89 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 489 | 0.150 |
Why?
|
| Transcription Factor AP-2 | 1 | 2017 | 22 | 0.140 |
Why?
|
| Drug-Seeking Behavior | 1 | 2016 | 6 | 0.140 |
Why?
|
| Heroin | 1 | 2016 | 19 | 0.130 |
Why?
|
| Carbamates | 1 | 2016 | 60 | 0.130 |
Why?
|
| Endocannabinoids | 1 | 2016 | 37 | 0.130 |
Why?
|
| Neuralgia | 1 | 2016 | 44 | 0.130 |
Why?
|
| Acetamides | 1 | 2016 | 47 | 0.130 |
Why?
|
| Morphine | 1 | 2016 | 83 | 0.130 |
Why?
|
| Anencephaly | 1 | 2016 | 11 | 0.130 |
Why?
|
| Thymus Gland | 2 | 2013 | 100 | 0.130 |
Why?
|
| Meningomyelocele | 1 | 2019 | 250 | 0.130 |
Why?
|
| Mice, Knockout | 9 | 2020 | 3745 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2020 | 3158 | 0.130 |
Why?
|
| Analgesics | 1 | 2016 | 127 | 0.120 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 656 | 0.120 |
Why?
|
| Cell Proliferation | 3 | 2018 | 2311 | 0.120 |
Why?
|
| Blood Proteins | 1 | 2016 | 124 | 0.120 |
Why?
|
| Cardiovascular System | 1 | 2016 | 107 | 0.120 |
Why?
|
| Autoimmunity | 1 | 2016 | 172 | 0.120 |
Why?
|
| Fetoscopy | 1 | 2019 | 447 | 0.120 |
Why?
|
| Reduced Folate Carrier Protein | 1 | 2014 | 20 | 0.110 |
Why?
|
| Microarray Analysis | 2 | 2012 | 229 | 0.110 |
Why?
|
| Cell Movement | 1 | 2017 | 847 | 0.110 |
Why?
|
| Endocytosis | 1 | 2014 | 125 | 0.110 |
Why?
|
| Endothelial Cells | 1 | 2016 | 526 | 0.100 |
Why?
|
| Glycerol-3-Phosphate O-Acyltransferase | 1 | 2012 | 1 | 0.100 |
Why?
|
| Glycerophospholipids | 1 | 2012 | 7 | 0.100 |
Why?
|
| Thymocytes | 1 | 2012 | 8 | 0.100 |
Why?
|
| Stilbenes | 1 | 2013 | 36 | 0.100 |
Why?
|
| Anti-Obesity Agents | 1 | 2013 | 41 | 0.100 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2013 | 42 | 0.100 |
Why?
|
| Tight Junctions | 1 | 2012 | 39 | 0.100 |
Why?
|
| PAX3 Transcription Factor | 1 | 2012 | 27 | 0.100 |
Why?
|
| Multigene Family | 2 | 2011 | 299 | 0.100 |
Why?
|
| Paired Box Transcription Factors | 1 | 2012 | 74 | 0.100 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 124 | 0.100 |
Why?
|
| Genomics | 1 | 2020 | 1499 | 0.100 |
Why?
|
| Analgesics, Opioid | 1 | 2016 | 404 | 0.100 |
Why?
|
| Central Nervous System Diseases | 1 | 2013 | 107 | 0.100 |
Why?
|
| Case-Control Studies | 5 | 2020 | 3304 | 0.090 |
Why?
|
| Cleft Palate | 2 | 2011 | 140 | 0.090 |
Why?
|
| Risk | 2 | 2016 | 756 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2018 | 1502 | 0.090 |
Why?
|
| Diet, High-Fat | 1 | 2013 | 211 | 0.090 |
Why?
|
| Immunoglobulin M | 2 | 2010 | 212 | 0.090 |
Why?
|
| Tobacco Use Disorder | 1 | 2011 | 90 | 0.090 |
Why?
|
| Biological Transport, Active | 3 | 2018 | 87 | 0.090 |
Why?
|
| Receptors, Nicotinic | 1 | 2011 | 155 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2020 | 2593 | 0.090 |
Why?
|
| Stress, Psychological | 1 | 2015 | 560 | 0.090 |
Why?
|
| Nicotine | 1 | 2011 | 143 | 0.090 |
Why?
|
| Hyperhomocysteinemia | 1 | 2009 | 38 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 2522 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2016 | 1697 | 0.070 |
Why?
|
| Mutation | 2 | 2020 | 5845 | 0.070 |
Why?
|
| Obesity | 2 | 2013 | 2248 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 1699 | 0.070 |
Why?
|
| Male | 10 | 2020 | 61560 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 1113 | 0.060 |
Why?
|
| Risk Factors | 4 | 2020 | 10319 | 0.060 |
Why?
|
| Arsenic | 1 | 2006 | 46 | 0.060 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 2 | 2018 | 70 | 0.060 |
Why?
|
| Bone and Bones | 1 | 2005 | 267 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2004 | 203 | 0.050 |
Why?
|
| Cell Polarity | 1 | 2024 | 121 | 0.050 |
Why?
|
| Carnitine O-Palmitoyltransferase | 2 | 2013 | 25 | 0.050 |
Why?
|
| Heart | 1 | 2007 | 730 | 0.050 |
Why?
|
| Maternal Exposure | 1 | 2004 | 149 | 0.050 |
Why?
|
| NIH 3T3 Cells | 1 | 2022 | 91 | 0.050 |
Why?
|
| Wnt Signaling Pathway | 1 | 2024 | 191 | 0.050 |
Why?
|
| Fever | 1 | 2004 | 299 | 0.050 |
Why?
|
| Genetic Techniques | 1 | 2002 | 106 | 0.050 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2004 | 259 | 0.050 |
Why?
|
| Organ Size | 2 | 2013 | 439 | 0.050 |
Why?
|
| Actins | 1 | 2024 | 346 | 0.050 |
Why?
|
| Genome | 1 | 2004 | 470 | 0.050 |
Why?
|
| Receptor, Muscarinic M1 | 1 | 2021 | 4 | 0.050 |
Why?
|
| Integrin alpha Chains | 1 | 2021 | 16 | 0.050 |
Why?
|
| Adult | 5 | 2018 | 29652 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2022 | 806 | 0.040 |
Why?
|
| Neuroaxonal Dystrophies | 1 | 2020 | 13 | 0.040 |
Why?
|
| Neurulation | 1 | 2020 | 22 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2016 | 1259 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 2021 | 152 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2024 | 888 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2020 | 459 | 0.040 |
Why?
|
| Gestational Age | 2 | 2016 | 1168 | 0.040 |
Why?
|
| Nervous System Malformations | 1 | 2020 | 130 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2021 | 335 | 0.040 |
Why?
|
| Sheep | 1 | 2019 | 220 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2021 | 432 | 0.040 |
Why?
|
| Logistic Models | 2 | 2016 | 1812 | 0.040 |
Why?
|
| Adiposity | 1 | 2020 | 190 | 0.040 |
Why?
|
| Homocystinuria | 1 | 2018 | 24 | 0.040 |
Why?
|
| Fetal Death | 1 | 2018 | 112 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2020 | 699 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2020 | 733 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2022 | 875 | 0.040 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2020 | 229 | 0.040 |
Why?
|
| Muscle Spasticity | 1 | 2018 | 73 | 0.040 |
Why?
|
| Teratoma | 1 | 2018 | 120 | 0.030 |
Why?
|
| Congenital Abnormalities | 1 | 2020 | 255 | 0.030 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2016 | 5 | 0.030 |
Why?
|
| Carrageenan | 1 | 2016 | 4 | 0.030 |
Why?
|
| Glycerides | 1 | 2016 | 15 | 0.030 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2016 | 28 | 0.030 |
Why?
|
| Sciatic Nerve | 1 | 2016 | 55 | 0.030 |
Why?
|
| Hyperalgesia | 1 | 2016 | 25 | 0.030 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2016 | 28 | 0.030 |
Why?
|
| Arachidonic Acids | 1 | 2016 | 29 | 0.030 |
Why?
|
| Pedigree | 1 | 2020 | 1606 | 0.030 |
Why?
|
| Psychotic Disorders | 1 | 2018 | 138 | 0.030 |
Why?
|
| DNA Damage | 1 | 2020 | 513 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2016 | 161 | 0.030 |
Why?
|
| DNA Repair | 1 | 2020 | 585 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 2016 | 82 | 0.030 |
Why?
|
| Drug Tolerance | 1 | 2016 | 40 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2020 | 3465 | 0.030 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2016 | 108 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 813 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 2007 | 1826 | 0.030 |
Why?
|
| Diet | 2 | 2016 | 1140 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2016 | 312 | 0.030 |
Why?
|
| China | 1 | 2016 | 246 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 388 | 0.030 |
Why?
|
| Fetus | 1 | 2018 | 585 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 3056 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2021 | 1007 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 1756 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 824 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 1290 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 358 | 0.030 |
Why?
|
| Apoptosis | 1 | 2020 | 1806 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2007 | 1016 | 0.030 |
Why?
|
| Polychlorinated Dibenzodioxins | 1 | 2012 | 5 | 0.030 |
Why?
|
| Leucovorin | 1 | 2012 | 49 | 0.030 |
Why?
|
| Vitamin B Complex | 1 | 2012 | 41 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2012 | 384 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2011 | 150 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2011 | 61 | 0.020 |
Why?
|
| Corpus Striatum | 1 | 2011 | 93 | 0.020 |
Why?
|
| Norway | 1 | 2011 | 20 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 161 | 0.020 |
Why?
|
| Pancytopenia | 1 | 2011 | 41 | 0.020 |
Why?
|
| Erythropoiesis | 1 | 2011 | 39 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 98 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 2011 | 159 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2011 | 897 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 2011 | 190 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2011 | 177 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 357 | 0.020 |
Why?
|
| Denmark | 1 | 2010 | 34 | 0.020 |
Why?
|
| Spleen | 1 | 2011 | 281 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2013 | 465 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 657 | 0.020 |
Why?
|
| Neurons | 1 | 2020 | 1932 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1020 | 0.020 |
Why?
|
| Maternal Age | 1 | 2010 | 134 | 0.020 |
Why?
|
| Pregnancy Trimester, First | 1 | 2010 | 114 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 1314 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2012 | 789 | 0.020 |
Why?
|
| Cleft Lip | 1 | 2011 | 125 | 0.020 |
Why?
|
| Inflammation | 1 | 2016 | 1446 | 0.020 |
Why?
|
| Phenotype | 2 | 2011 | 4262 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 2637 | 0.020 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2009 | 14 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2011 | 325 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 989 | 0.020 |
Why?
|
| Binding Sites | 1 | 2011 | 1303 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2021 | 4534 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2011 | 454 | 0.020 |
Why?
|
| Methionine | 1 | 2009 | 102 | 0.020 |
Why?
|
| Motor Activity | 1 | 2011 | 520 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2020 | 8236 | 0.020 |
Why?
|
| Ephrins | 1 | 2006 | 5 | 0.020 |
Why?
|
| Seizures | 1 | 2011 | 872 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 3103 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2006 | 45 | 0.020 |
Why?
|
| Hippocampus | 1 | 2011 | 826 | 0.020 |
Why?
|
| RNA, Antisense | 1 | 2005 | 34 | 0.020 |
Why?
|
| Biological Transport | 1 | 2006 | 356 | 0.020 |
Why?
|
| Pharmacogenetics | 1 | 2005 | 184 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2013 | 1726 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2004 | 75 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2004 | 163 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2004 | 132 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2004 | 395 | 0.010 |
Why?
|
| Heterozygote | 1 | 2004 | 671 | 0.010 |
Why?
|
| Liver | 1 | 2009 | 1748 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 1078 | 0.010 |
Why?
|
| Brain | 1 | 2013 | 3004 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 12517 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2006 | 2820 | 0.010 |
Why?
|
| Age Factors | 1 | 2006 | 2825 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2010 | 6158 | 0.010 |
Why?
|